Roche Holding AG Basel American Depositary Shares (OP:RHHBY)
Delayed: 65.65 --0 (-0%)
Trade Now!
Previous Close $65.65    52 Week High $66.52 
Open $65.90    52 Week Low $38.63 
Day High $66.52    P/E N/A 
Day Low $65.50    EPS $0.00 
Volume 453,688       

Friends, Peers and Foes (?): RO, ILMN, IMGN, ROG, RHO (more...)

May 15, 2013 06:00 PM Genentech’s Obinutuzumab (GA101) Significantly Reduced the Risk of Disease Progression or Death in People with One of the Most Common Forms of Blood Cancer
May 15, 2013 01:00 AM Genentech to Present Important New Data Reflecting Broad Cancer Pipeline at ASCO
May 14, 2013 07:14 PM FDA Approves Tarceva (Erlotinib) Tablets and Cobas EGFR Mutation Test for Specific Type of Lung Cancer
May 10, 2013 03:58 PM Roche (RHHBY) Spokesperson: Illumina (ILMN) Still 'Off the Table'
Apr 30, 2013 11:31 AM Roche's (RHHBY) Genentech Receives FDA Approval for ACTEMRA as PJIA Treatment
Apr 30, 2013 11:30 AM FDA Approves ACTEMRA® for Children Living with a Rare Form of Arthritis
Apr 22, 2013 01:46 AM Evotec Extends Drug Discovery Alliance With Genentech
Apr 16, 2013 11:42 AM UPDATE: Glaxo (GSK) wins appeals court ruling over Biogen Idec (BIIB) cancer patent
Apr 11, 2013 08:15 AM Roche Holding (RHHBY) Reports 5.1% Growth in Q1 Sales
Apr 8, 2013 09:02 AM Roche (RHHBY), Isis Pharma (ISIS) Enter Huntington's Disease Agreement; Value to Isis at $362M
View All Articles

Entities mentioned with RHHBY

View All Entities